DRAMATICALLY EFFECTIVE CANCER TREATMENT IN FINAL DEVELOPMENT FOR SOFT TISSUE CANCERS OF THE LIVER, BREAST AND LUNGS - by a company that just went public last week! Now you can participate in the multi-billion dollar cancer treatment industry by owning stock in this company before the "Wall Street Analysts" discover it. The company is in the final stages of researching and developing this new drug to help cure soft tissue cancers of the liver, breast and lungs. This company is led by a very distinguished team of Cancer Research Specialists who have studied this disease for the last two decades. The company holds the worldwide manufacturing and marketing rights (except for the former Soviet Union) for this drug. The company is called : NuOncology Labs Inc. Trading Symbol: NLAB Trades: OTC BB 'NLAB' started trading last Thursday,July 9, at: $5 15/32 At the market close Friday, July 10, it was: $6 1/8 Trials are now being conducted on over 200 human cancer patients with this new drug and some very important announcements are expected to come from NuOncology over the next few weeks. To have complete investor information sent to you via e-mail on this innovative new pharmaceutical research and development company just : Click Here You will get back complete information via e-mail within the next 24 hours on : NuOncology Labs, Inc. We profile companies at the time they initially go public - before they have been discovered by 'The Street' and financial media and have by that time already doubled or tripled in price. By requesting additional information on NuOncology Labs, Inc., you are also requesting a subscription to our newsletter that profiles emerging new companies. There is no obligation and absolutely no cost to you. You may unsubscribe at any time.